P
Psicomed Estudios Medicos | Antofagasta, Chile
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
ACP-204
Seltorexant
Pimavanserin
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 4 total trials
This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies...
Enrolling
Alzheimer's Disease Psychosis
Drug: Placebo
Drug: ACP-204
This 52-week, open-label extension study is to evaluate the long-term safety and tolerability of ACP-204 in subjects with ADP.
Invitation-only
Alzheimer's Disease Psychosis
Drug: ACP-204
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems